LogoLogo
  • About Us
    • About Aurobindo
    • Vision / Mission
    • Milestones
    • R&D
    • Manufacturing
    • Management
      • Board of Directors
    • Our Presence
  • Our Business
    • APUSA
    • Europe
    • Growth Markets
    • ARV
      • Overview
      • Key facts about HIV/AIDS
      • Products
      • Global Partners
      • Gallery
      • Corporate Video
    • Apitoria (API)
    • Eugia (Speciality products)
    • Curateq (Biosimilars) / Peptide
  • Sustainability
    • ESG / Sustainability
      • ESG Profile
      • Sustainability Reports
      • BMW Reports
    • Social Accountability Standards
      • Social Compliance Certification
      • Sustainability of Social Accountability Standards
      • Human Rights Policy
      • Progressive Health and Safety Practices
      • Community Impact
      • Supply Chain Management
      • Supplier Code of Conduct
    • CSR
      • Aurobindo Pharma Foundation
      • CSR Policy
      • Annual Report
      • Gallery
      • Annual Action Plan
      • Impact Assessment Reports - CSR Projects
    • Access to Healthcare
      • PEPFAR program
  • Investors
    • Results, Reports & Presentations
      • Results Announcements
      • Annual Reports
      • Financials - Subsidiaries
      • Related Party Transactions
    • Shareholder Information
      • Shareholding Pattern
      • Buyback of shares
      • Share Performance
      • Financial Highlights
      • Notice of Board Meetings
      • General Meetings
      • Dividend Record
      • Scheme of Arrangements
      • Unpaid Dividend Account Details
      • Registrar and Share Transfer Agent
      • Contact Details for Investor Grievance Redressal
    • Corporate Governance
      • Board of Directors
      • Governance Policies
      • Code of Conduct
      • Code of Practices and Procedures for Fair Disclosure
      • Appointment and Resignation of Directors
      • Contact Details of KMPs
      • IR Contacts
    • Disclosures Under Regulation 46
      • Disclosures under Regulation 46 of the LODR
  • Media
    • Press Releases
    • Corporate Kit
  • Careers
    • Our Culture & Values
    • Life @ Aurobindo
    • Work with us / Oppurtunities
  • Contact Us

Investors

Commitment towards creating consistent value for our shareholders

Annual Secretarial Compliance Report

Annual Secretarial Compliance Report 31.03.2025

PDF icon

Annual Secretarial Compliance Report – 31.03.2024

PDF icon

Annual Secretarial Compliance Report -31.03.2023

PDF icon

Annual Secretarial Compliance Report – 31.03.2022

PDF icon

Annual Secretarial Compliance Report - 31.03.2021

PDF icon
Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

  • About Us
  • Our Business
  • Sustainability
  • Investors
  • Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.